In 2006, Dhein and colleagues [24] demonstrated for the first time that intramyocardial injection of BM-MSC normalized both circulating catecholamine levels and β-AR density in the heart after four weeks in a model of non-ischemic cardiomyopathy in rabbits. The gene discussed is ADRB2; the disease is ischemic cardiomyopathy.